comparemela.com

Alankar Garude News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Deal valuations weigh on Apollo Hospitals stock

Deal valuations weigh on Apollo Hospitals stock
rediff.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rediff.com Daily Mail and Mail on Sunday newspapers.

Aashita jainAlankar garudeShrikant akolkarApollo healthcoNuvama researchPrabhudas lilladher researchAdvent internationalApollo hospitals enterpriseInstitutional equitiesFinancial yearPrabhudas lilladher

Occupancy surge, pharmacy profitability key triggers for Apollo Hospitals

The June quarter numbers of the country s largest listed healthcare services provider, Apollo Hospitals Enterprise (Apollo), were in line with Street estimates on the operational front. Net profit estimates, however, missed expectations due to higher interest and tax outgo. The revenue performance of the core hospital segment was robust, registering a 13 per cent increase over the year-ago quarter.

Andhra pradeshAlankar garudeMotilal oswal researchApollo hospitals enterpriseNavi mumbaiKotak institutional equitiesOswal researchBusiness newsUsiness news indiaNdia business newsNdian economy newsNdian financial news

Short Call | Street looks for next best ideas as focus shifts to MCX, Colgate, Dr Lal Path Labs

Short Call | Street looks for next best ideas as focus shifts to MCX, Colgate, Dr Lal Path Labs
moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.

Aniket singhSamitinjoy basakCharles ellisBharath uppiliappanPrabhudas lilladherAlankar garudeMotilal oswalMulti commodity exchangeCompetition commission of indiaCommodity exchangeCompetition commissionColgate indiaLal pathInstitutional equities

Short Call | Chemistry goes wrong, but diagnostics a hit; Varun Beverages right choice, baby?

There is a saying in the stock market that irrespective of whether an investor makes or loses money on a trade, the broker always makes money on it. Something similar seems to be playing out in the FMCG space

Hemkesh khattarJean paul kauffmannAlankar garudeMotilal oswalMichael harzMoneycontroln mahalakshmiSunil singhaniaSamitinjoy basakAniket singhValue researchKotak institutional equitiesHai diversified choicePepsico indiaVarun beveragesFreiberger compound

gSpiriva approval gives earnings visibility to Lupin; valuations expensive

Lupin's shares declined 4 per cent in Thursday's intra-day trade despite receiving the final approval of the USFDA for inhalation drug gSpiriva

Alankar garudeAniket singhSamitinjoy basakDrug administrationTiotropium bromideKotak institutional equities

vimarsana © 2020. All Rights Reserved.